Lower incidence of de novo donor-specific antibodies against HLA-DR in ABO-incompatible renal transplantation.

[1]  Masafumi Nakamura,et al.  Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies , 2017, Transplantation.

[2]  B. Meiser,et al.  De novo donor‐specific anti‐HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q‐binding ability , 2017, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  Y. Kodera,et al.  Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibition. , 2017, Transplant immunology.

[4]  N. Goto,et al.  De Novo Anti-HLA DSA Characteristics and Subclinical Antibody-Mediated Kidney Allograft Injury , 2016, Transplantation.

[5]  Kota Takahashi,et al.  [ABO-incompatible kidney transplantation]. , 2016, Nihon rinsho. Japanese journal of clinical medicine.

[6]  J. Craig,et al.  Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation: A Systematic Review and Meta-Analysis , 2016, Transplantation.

[7]  B. Chung,et al.  Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients , 2016, Medicine.

[8]  Miriam Manook,et al.  Difference in outcomes after antibody‐mediated rejection between abo‐incompatible and positive cross‐match transplantations , 2015, Transplant international : official journal of the European Society for Organ Transplantation.

[9]  M. Seidl,et al.  An update on ABO‐incompatible kidney transplantation , 2015, Transplant international : official journal of the European Society for Organ Transplantation.

[10]  Kota Takahashi,et al.  Trends in ABO-incompatible kidney transplantation. , 2015, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[11]  K. Iwasaki,et al.  AMP‐activated protein kinase as a promoting factor, but complement and thrombin as limiting factors for acquisition of cytoprotection: implications for induction of accommodation , 2013, Transplant international : official journal of the European Society for Organ Transplantation.

[12]  N. Goto,et al.  Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches. , 2013, Human immunology.

[13]  C. Haisch,et al.  The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes , 2013, Transplantation.

[14]  P. Nickerson,et al.  Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  K. Iwasaki,et al.  Comparative Study on Signal Transduction in Endothelial Cells After Anti-A/B and Human Leukocyte Antigen Antibody Reaction: Implication of Accommodation , 2012, Transplantation.

[16]  W. Chapman,et al.  Mechanism of Accommodation in a Sensitized Human Leukocyte Antigen Transgenic Murine Cardiac Transplant Model , 2012, Transplantation.

[17]  E. Reed,et al.  Effect of Antibodies on Endothelium , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  R. Colvin,et al.  Kidney transplantation: mechanisms of rejection and acceptance. , 2008, Annual review of pathology.

[19]  K. Tanabe.  Japanese Experience of ABO-Incompatible Living Kidney Transplantation , 2007, Transplantation.

[20]  A. Chong,et al.  Expression of Complement Regulatory Proteins in Accommodated Xenografts Induced by Anti‐α‐Gal IgG1 in a Rat‐to‐Mouse Model , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  Kota Takahashi,et al.  Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation , 2007, Clinical and Experimental Nephrology.

[22]  K. Muczynski,et al.  Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium. , 2001, Kidney international.

[23]  N. Goto,et al.  Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation. , 2014, Kidney international.

[24]  Takaaki Kobayashi,et al.  Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation. , 2011, Human immunology.

[25]  E. Reed,et al.  Role of anti-MHC class I antibody in facilitating transplant accommodation. , 2008, Critical reviews in immunology.

[26]  T. Mohanakumar,et al.  HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. , 2006, Transplant immunology.

[27]  R. Waldherr,et al.  [Expression of class I and class II histocompatibility antigens in inflammatory kidney diseases]. , 1989, Verhandlungen der Deutschen Gesellschaft fur Pathologie.